HomeCompareGGLDF vs JNJ

GGLDF vs JNJ: Dividend Comparison 2026

GGLDF yields 1117.32% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GGLDF wins by $49895095.08M in total portfolio value
10 years
GGLDF
GGLDF
● Live price
1117.32%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49895095.11M
Annual income
$42,425,635,717,569.89
Full GGLDF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GGLDF vs JNJ

📍 GGLDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGGLDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GGLDF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GGLDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GGLDF
Annual income on $10K today (after 15% tax)
$94,972.07/yr
After 10yr DRIP, annual income (after tax)
$36,061,790,359,934.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GGLDF beats the other by $36,061,790,355,948.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GGLDF + JNJ for your $10,000?

GGLDF: 50%JNJ: 50%
100% JNJ50/50100% GGLDF
Portfolio after 10yr
$24947547.57M
Annual income
$21,212,817,861,129.65/yr
Blended yield
85.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GGLDF
No analyst data
Altman Z
120.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GGLDF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGGLDFJNJ
Forward yield1117.32%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$49895095.11M$30.3K
Annual income after 10y$42,425,635,717,569.89$4,689.40
Total dividends collected$49332813.79M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GGLDF vs JNJ ($10,000, DRIP)

YearGGLDF PortfolioGGLDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$122,432$111,731.84$10,592$272.30+$111.8KGGLDF
2$1,409,463$1,278,461.27$11,289$357.73+$1.40MGGLDF
3$15,263,208$13,755,082.35$12,123$472.89+$15.25MGGLDF
4$155,541,961$139,210,328.34$13,141$629.86+$155.53MGGLDF
5$1,492,264,729$1,325,834,830.62$14,408$846.81+$1492.25MGGLDF
6$13,484,590,610$11,887,867,350.31$16,021$1,151.60+$13484.57MGGLDF
7$114,823,507,422$100,394,995,469.18$18,122$1,588.22+$114823.49MGGLDF
8$921,814,332,935$798,953,179,993.63$20,930$2,228.20+$921814.31MGGLDF
9$6,980,803,174,083$5,994,461,837,842.63$24,792$3,191.91+$6980803.15MGGLDF
10$49,895,095,113,839$42,425,635,717,569.89$30,274$4,689.40+$49895095.08MGGLDF

GGLDF vs JNJ: Complete Analysis 2026

GGLDFStock

Getchell Gold Corp., a junior resource exploration company, engages in the identification, acquisition, exploration, and development of precious and base metal mineral resource properties in the United States. The company primarily explores for gold, silver, and copper deposits. It holds interests in the Fondaway Canyon property comprising 171 claims; and the Dixie Comstock property that consists of 28 claims located in the Churchill County, Nevada. The company also holds interests in the Star property comprises 199 unpatented mining claims situated in Pershing County, Nevada; and the Hot Springs Peak property that consists of 167 unpatented lode mining claims located in the northern Hot Springs range in Humboldt County, Nevada. Getchell Gold Corp. is headquartered in Vancouver, Canada.

Full GGLDF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GGLDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GGLDF vs SCHDGGLDF vs JEPIGGLDF vs OGGLDF vs KOGGLDF vs MAINGGLDF vs ABBVGGLDF vs MRKGGLDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.